2005The Journal of UrologyRequires access

RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION

Kieran Jefferson, Aloy Okeke, Raj Persad

Open publisher page 0 citations

Abstract

No AccessJournal of UrologyLetters to the Editor/Errata1 Mar 2005RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTIONis correction ofALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)60452-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION." The Journal of Urology, 173(3), p. 1050 References 1 : Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol2002; 42: 329. Google Scholar 2 : The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol1998; 81: 712. Google Scholar 3 : Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled trial. BJU Int1999; 84: 622. Google Scholar 4 : Continuing alfuzosin therapy following successful TWOC in benign prostatic hyperplasia (BPH) reduces risk of acute urinary retention (AUR) relapse and need for surgery. J Urol2004; 171: 243. abstract 916. Link, Google Scholar 5 McNeill, S.A. and Hargreave, T. B. on behalf of ALFAUR Study Group: Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind, placebo-controlled controlled study. Unpublished data. Google Scholar 6 : The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol2004; 45: 325. Google Scholar © 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology9 Nov 2018ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION Volume 173Issue 3March 2005Page: 1050 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.MetricsAuthor Information Expand All Advertisement PDF downloadLoading ...

About this research paper

What this paper is about

No AccessJournal of UrologyLetters to the Editor/Errata1 Mar 2005RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTIONis correction ofALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)60452-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION." The Journal of Urology, 173(3), p. 1050 References 1 : Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol2002; 42: 329. Google Scholar 2 : The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol1998; 81: 712. Google Scholar 3 : Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled trial. BJU Int1999; 84: 622. Google Scholar 4 : Continuing alfuzosin therapy following successful TWOC in benign prostatic hyperplasia (BPH) reduces risk of acute urinary retention (AUR) relapse and need for surgery. J Urol2004; 171: 243. abstract 916. Link, Google Scholar 5 McNeill, S.A. and Hargreave, T. B. on behalf of ALFAUR Study Group: Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind, placebo-controlled controlled study. Unpublished data. Google Scholar 6 : The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol2004; 45: 325. Google Scholar © 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology9 Nov 2018ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION Volume 173Issue 3March 2005Page: 1050 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.MetricsAuthor Information Expand All Advertisement PDF downloadLoading ...

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

No AccessJournal of UrologyLetters to the Editor/Errata1 Mar 2005RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTIONis correction ofALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)60452-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION." The Journal of Urology, 173(3), p. 1050 References 1 : Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention. Eur Urol2002; 42: 329. Google Scholar 2 : The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol1998; 81: 712. Google Scholar 3 : Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled trial. BJU Int1999; 84: 622. Google Scholar 4 : Continuing alfuzosin therapy following successful TWOC in benign prostatic hyperplasia (BPH) reduces risk of acute urinary retention (AUR) relapse and need for surgery. J Urol2004; 171: 243. abstract 916. Link, Google Scholar 5 McNeill, S.A. and Hargreave, T. B. on behalf of ALFAUR Study Group: Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind, placebo-controlled controlled study. Unpublished data. Google Scholar 6 : The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Eur Urol2004; 45: 325. Google Scholar © 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology9 Nov 2018ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION Volume 173Issue 3March 2005Page: 1050 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.MetricsAuthor Information Expand All Advertisement PDF downloadLoading ...

Key concepts: Alfuzosin, Urinary retention, Medicine, Placebo, Urology, Prostatectomy, Internal medicine, Prostate

Related papers

Back to paper searchBrowse research topicsOriginal source
RE: ALFUZOSIN ONCE DAILY FACILITATES RETURN TO VOIDING IN PATIENTS IN ACUTE URINARY RETENTION — Research Paper | ScholarLens